Dosimetry calculation for a novel PHOSPHORUS-32- impregnated balloon angioplasty catheter for intravascular brachytherapy

Cardiovascular Radiation Medicine

Volumn 1, Issue 4, 1999, Pages 349-357

  Yue, Ning ^a   Nath, Ravinder ^a   Hehrlein, Christoph ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BORGESS MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Intravascular brachytherapy; Monte Carlo simulation; Restenosis, Phosphorus 32

Indexed keywords

PHOSPHORUS;

ARTICLE; BRACHYTHERAPY; HUMAN; INSTRUMENTATION; METHODOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RADIOMETRY; THEORETICAL MODEL;

ANGIOPLASTY, BALLOON; BRACHYTHERAPY; HUMANS; MODELS, THEORETICAL; PHOSPHORUS RADIOISOTOPES; RADIOMETRY;

EID: 0033207022     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(00)00022-6     Document Type: Article

References (16)

1. Pocock S.J., Henderson R.A., Rickards A.F.et al. Meta analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet. 346:1995;1184-1189.
2. Waksman R. Radiation for prevention of restenosis. where are we? Int. J. Radiat. Oncol. Biol. Phys. 36:1996;959-961.
3. Shimotakahara S., Mayberg A.R. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke. 25:1994;424-428.
4. Wiedermann J.G., Marboe C., Amols H.et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J. Am. Coll. Cardiol. 23:1994;1491-1498.
5. 192Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels. 6 years of experience Int. J. Radiat. Oncol. Biol. Phys. 36:1996;835-840.
6. Teirstein P.S., Massullo V., Jani S.et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N. Engl. J. Med. 336:1997;1697-1703.
7. Amols H.I., Zaider M., Weinberger J.et al. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;913-921.
8. Hehrlein C, Kovacs A, Yue N, et al. A novel balloon angioplasty catheter impregnated with β-particle emitting radioisotopes for prevention of restenosis: experimental results. Submitted to Catheterization Cardiovasc. Intervent.
9. Fischell T.A., Carter A.J., Laird J.R. The beta-particle-emitting radioisotope stent (isostent). animal studies and planned clinical trials Am. J. Cardiol. 78(3A):1996;45-50.
10. 32P-coated stent. Med. Phys. 22:1994;313-320.
11. Dillman L.T. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation (MIRD pamphlet no. 4). J. Nucl. Med. 10(suppl 2):1969;5-32.
12. Prestwich W.V., Nunes J., Kwok C.S. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J. Nucl. Med. 30:1989;1036-1046.
13. Coursey B.M., Colle R., Zimmerman B.E.et al. National radioactivity standards for β-emitting radionuclides used in intravascular brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;207-216.
14. Popowski Y., Verin V., Papirov I.et al. High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty. preliminary dosimetric tests of a new source presentation Int. J. Radiat. Oncol. Biol. Phys. 33:1995;211-215.
15. 90Y brachytherapy. preliminary dosimetry study using a specially modified angioplasty balloon Int. J. Radiat. Oncol. Biol. Phys. 33:1995;713-717.
16. Xu Z., Almond P.R., Deasy J.O. The dose distribution produced by a 32P source for endovascular irradiation. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;933-939.